The Global Market for Membrane Microfiltration

The global market for microfiltration (MF) membrane products used in liquid separations is estimated at $1.24 billion in 2010 and is projected to increase to $1.82 billion by 2015, for a 5-year compound annual growth rate (CAGR) of 8%.
Learn about the market for MF products as reflected by the major applications of the technology and get information on the industry structure, trends, pricing considerations, R&D, government regulations, company profiles and competitive technologies...

Use this report to:

• Receive in-depth analysis of the technical and market drivers relating to the market for microfiltration (MF) membrane products: modules, capsules, cartridges, and cassettes.
• Understand the current worth of MF products by application, and forecasts growth and trends in the various sectors over the next 5 years, with important statistical information on markets, applications, industry structure, and dynamics along with technological developments.
• See 5-year projections for MF membrane products major applications of the technology: food and beverage processing, biopharmaceuticals manufacture, potable water production, wastewater treatment, industrial processes, and semiconductor fabrication.
• Determine the industry structure, membrane applications and trends, pricing considerations, R&D, government regulations, company profiles and competitive technologies are included in the study for the global market applied to liquid separations.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order

Global market for antifungal drugs & technologies worth $11.8 billion by 2014

The global human antifungal therapeutics market was worth around $10.2 billion in 2008 and it decreased in 2009 to be around $9.9 billion. However, the market is anticipated to reach $11.8 billion in 2014 at a 5 year CAGR of 3.8%.

Learn about the major markets for antifungal applications in human healthcare, with an extensive review of therapies in human development phases I-III...

Use this report to:

• Receive in-depth analysis of the current human antifungal market and explore the direction the market is going, with a strong emphasis on early research due to the critical need for new and more effective medicines
• Understand the human applications both marketed and in the development of antifungal technology; extensive analysis of each market segment, current market status, and forecasts for growth over the next 5 years
• See 5-year financial and sales projections and trends from 2009 through 2014; based on other factors such as FDA restrictions, government legislation, fungal resistance, and changes in the consumerism as a greater demand for OTC medications and/or natural and alternative remedies has arose
• Determine the current status of the global human antifungal market and assess its growth potential over the 5 year period from 2009 through 2014.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

Plastics for Healthcare Packaging

The plastic healthcare packaging market (by resin type) is estimated at about 3.6 billion pounds in 2009 and at 3.8 billion pounds in 2010. It is expected to increase to almost 5 billion pounds by 2015, which corresponds to a 5.6% compound annual growth rate (CAGR).

Learn about the trends in the plastics packaging of pharmaceutical products and medical products market, such as blood and intravenous solution bags, diagnostics kits, syringes and similar items through 2015...

Use this report to:

• Receive analysis, market trends and forecasts for major plastics used in packaging important healthcare products
• Understand the uses and differences for plastics in the packaging of healthcare products segmented by pharmaceutical and medical packaging
• Determine the most important economic, technological, regulatory, and environmental considerations in U.S. markets for the use of plastics to package healthcare products
• See market trends and projections for the United States as well as some international activities for polymer and packaging chemistry in both the plastics and healthcare industries.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

Telematics market worth $40.3 billion by 2016

Telematic Components: Technologies and Global Markets

In 2008, total net market value for telematics was $11.6 billion. In 2009, this total decreased to $11.5 billion as unit sales declined due to the worldwide economic recession. It is projected to reach $40.3 billion in 2016 at a 5 year CAGR of 20.9%.

Learn about the telematics industry and its products and technologies used in consumer and commercial vehicles through 2016...

Use this report to:

• Receive an overview of the telematics products use in vehicles, which can be broadly segregated into hardware including tracking, connection, sensors, and user interface, as well as software that includes embedded operating systems that control the systems
• Understand analysis and forecasts of market opportunities for components related to telematics applications for the time span extending from 2011 to 2016
• Determine the drivers and market trends of both commercial and consumer vehicle markets that will allow the emerging telematics systems to emerge into the mainstream market, and the significant changes occurring in the general automotive industry as well as demographic changes that will allow for these opportunities.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

Emerging Markets for Advanced Medical Technologies

The total market for the advanced medical technologies was valued at $12.5 billion in 2008 and $13.5 billion in 2009. Growing at a compound annual growth rate (CAGR) of 12.7%, this market is expected to be valued at nearly $24.6 billion by 2014.

Analyze the breakdown of advanced technologies, such as imaging, patient monitoring, surgical devices, cardiovascular devices, and medical automation equipment through 2014...

Use this report to:

• Receive analysis of the demographic, economic, policy, and regulatory forces that will influence the future size and structure of the market for advanced medical devices in the largest emerging markets
• Determine the medical device technologies and applications with the greatest commercial potential from 2008 to 2014
• Understand the emerging markets, demographics, economics, health care systems, medical equipment imports, and market for the following medical technologies: imaging and visualization, patient monitoring, surgical devices, cardiovascular devices, orthopedic implants, renal devices, biochips, and other advanced technologies(neurostimulators, implantable drug pumps, etc).

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

Global market for genetic disorder products to reach $17.3 billion by 2014

Biotechnology Market Data Just Published by BCC Research

The global market for genetic disorder products was valued at $12.2 billion in 2008, which increased to $12.8 billion in 2009. Growing at a compound annual growth rate (CAGR) of 6.2%, this market is expected to be valued at nearly $17.3 billion by 2014.

Examine the market in chromosomal disorders, such as Down, Klinefelter’s, Prader-Willi, and Turner’s syndromes through 2014...

Use this report to:

• Receive an overview of a range of genetic disorders, both mutation and chromosomal in nature, and provide global market summaries and new research and developments for treating genetic disorders
• Understand the new developments in treating genetic disorders with product descriptions, discussions of new research, and company profiles from 2009 through 2014; as well as issues affecting the current and forecasted market, patent information and a list of key organizations covering genetic disorders.
• See current product availability, uses of products, forecasts, and competitive analyses for a specific range of genetic disorders: Cystic Fibrosis, Fabry disease, Gaucher’s disease, Hemophilia, Huntington’s disease, Hunter syndrome, Hurler syndrome, Klinefelter syndrome, Maroteaux-Lamy syndrome, Phenylketonuria (PKU), Prader-Willi syndrome, Pompe disease, Turner’s syndrome.
• Determine the areas of genetic disorders and the demand for new development that have emerged from biopharmaceutical companies, governments, private organizations, and universities with the current and potential market growth through 2014.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

Therapeutic Vaccines: The Global Market

Biotechnology Market Data Just Published by BCC Research

The total worldwide market for therapeutic vaccines is expected to reach $137 million in 2010 and $425 million in 2011. With increased product introductions, this market is expected to reach nearly $3.1 billion in 2014 at a 5 year CAGR of 117%.

Use this report to:

• Receive analysis for each therapeutic vaccine on the market and almost all therapeutic vaccines in mid-to-late stages of development, we have examined where they stand in the drug development process, major challenges to their approval or market success, achievements and, where applicable, the projected market for each of these drugs through 2014.
• Determine the current status of the therapeutic vaccines industry and assess its growth potential over a 5-year period from 2010 to 2015
• See technical descriptions and challenges , applications, major players, international aspects, and projected growth for some of these therapeutic vaccines through 2014
• Understand trends that are assessed based on projected sales of new products being introduced, competitive advantages of emerging technologies as well as other factors such as increases in the prevalence of certain diseases; with forecasts by product segment and indications from 2009 through 2014 including supporting analysis for projections.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order

Epigenomics: Emerging Opportunities in Biomarkers, Diagnostics and Therapeutics

Global market for Epigenomic Products was $662 billion in 2008, which increased to $930.6 million 2009, it is projected to reach $6 billion in 2014 at a 5 year CAGR of 45.4%.

Learn major Epigenomics technologies impacting the market today and emerging opportunities in biomarkers, diagnostics and therapeutics through 2014...

Use this report to:


• Receive a comprehensive discussion of where the state of the art is in epigenomics technologies and the current and future commercial potential for these key market segments, along with a study of the current large-scale epigenome funding projects as well as the industry competitive and patent dynamics


• Determine the status of commercial epigenomics technologies and products and assess their worldwide growth potential over a 5 year period from 2009 through 2014; by the four main segments for epigenomics: research tools, diagnostics, therapeutics, and assays for cellular therapies


• See the major epigenomics technologies that are now, or likely to become commercialized within the next 5 years, and examine the products from these technologies, market segments of the products, and sales forecasts and trends for 2009 through 2014


• Understand the fundamental epigenomic technologies, the market driving forces, product types, main market applications, key companies, strategic alliances and acquisitions, future global market potential and product sales forecasts for the period of 2009 through 2014.


Click here for more detailed information.


To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.